Fuji Pharma Co., Ltd. (FRA:FUP)

Market Cap	216.35M
Revenue (ttm)	294.72M
Net Income (ttm)	18.10M
Shares Out	n/a
EPS (ttm)	0.74
PE Ratio	11.96
Forward PE	n/a
Dividend	0.27 (3.04%)
Ex-Dividend Date	Sep 29, 2025

Volume	10
Average Volume	1
Open	8.85
Previous Close	8.95
Day's Range	8.85 - 8.85
52-Week Range	7.25 - 10.30
Beta	n/a
RSI	51.21
Earnings Date	Nov 11, 2025

About Fuji Pharma

Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, as well as information regarding pharmaceuticals and health; and contract manufacturing services. Fuji Pharma Co., Ltd. was founded in 1959 and is headquartered in Tokyo, Japan.

• Industry: Pharmaceutical Preparations
• Founded: 1959
• Employees: 1,658
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FUP

Financial Performance

In 2024, Fuji Pharma's revenue was 46.14 billion, an increase of 12.84% compared to the previous year's 40.89 billion. Earnings were 6.15 billion, an increase of 78.92%.

Financial numbers in JPY